Approximately 15 years ago, scientists first saw the potential of an engineered, bacteria-derived genetic machinery for incorporating non-canonical amino acids into proteins produced in eukaryotic cells. But the method has faced a number of technical restrictions that limited its widespread development. Researchers have developed a new method that overcomes many of the previous obstacles.
